Literature DB >> 34162231

Nrg1β as a Proangiogenesis Therapy: How Is Nrg1β Therapy Unique From Other Angiogenesis Therapies?

Ying H Shen1, Jun-Ichi Abe2.   

Abstract

Entities:  

Keywords:  Editorials; angiogenesis; cardiomyopathy; endothelium; hypoxia; inflammation; remote ischemic preconditioning

Year:  2021        PMID： 34162231      PMCID： PMC8631478          DOI： 10.1161/ATVBAHA.121.316513

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN： 1079-5642            Impact factor:   10.514


× No keyword cloud information.
  30 in total

1.  CXCR4 blockade augments bone marrow progenitor cell recruitment to the neovasculature and reduces mortality after myocardial infarction.

Authors:  Kentaro Jujo; Hiromichi Hamada; Atsushi Iwakura; Tina Thorne; Haruki Sekiguchi; Trevor Clarke; Aiko Ito; Sol Misener; Toshikazu Tanaka; Ekaterina Klyachko; Koichi Kobayashi; Jörn Tongers; Jérôme Roncalli; Yukio Tsurumi; Nobuhisa Hagiwara; Douglas W Losordo
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-01       Impact factor: 11.205

2.  Cardiac endothelial cells regulate reactive oxygen species-induced cardiomyocyte apoptosis through neuregulin-1beta/erbB4 signaling.

Authors:  Yukio Kuramochi; Gregory M Cote; Xinxin Guo; Nathan K Lebrasseur; Lei Cui; Ronglih Liao; Douglas B Sawyer
Journal:  J Biol Chem       Date:  2004-09-21       Impact factor: 5.157

3.  Loss of Endothelial CXCR7 Impairs Vascular Homeostasis and Cardiac Remodeling After Myocardial Infarction: Implications for Cardiovascular Drug Discovery.

Authors:  Huifeng Hao; Sheng Hu; Hong Chen; Dawei Bu; Liyuan Zhu; Chuansheng Xu; Fei Chu; Xingyu Huo; Yue Tang; Xiaogang Sun; Bi-Sen Ding; De-Pei Liu; Shengshou Hu; Miao Wang
Journal:  Circulation       Date:  2017-02-02       Impact factor: 29.690

4.  Angiogenic Gene Therapy (AGENT) trial in patients with stable angina pectoris.

Authors:  Cindy L Grines; Matthew W Watkins; Greg Helmer; William Penny; Jeffrey Brinker; Jonathan D Marmur; Andrew West; Jeffery J Rade; Pran Marrott; H Kirk Hammond; Robert L Engler
Journal:  Circulation       Date:  2002-03-19       Impact factor: 29.690

5.  Inhibitory actions of the NRG-1/ErbB4 pathway in macrophages during tissue fibrosis in the heart, skin, and lung.

Authors:  Zarha Vermeulen; Anne-Sophie Hervent; Lindsey Dugaucquier; Leni Vandekerckhove; Miche Rombouts; Matthias Beyens; Dorien M Schrijvers; Guido R Y De Meyer; Stuart Maudsley; Gilles W De Keulenaer; Vincent F M Segers
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-08-19       Impact factor: 4.733

Review 6.  Cellular cross-talks in the diseased and aging heart.

Authors:  Julian U G Wagner; Stefanie Dimmeler
Journal:  J Mol Cell Cardiol       Date:  2019-11-26       Impact factor: 5.000

7.  Neuregulin-1 protects ventricular myocytes from anthracycline-induced apoptosis via erbB4-dependent activation of PI3-kinase/Akt.

Authors:  Ryuji Fukazawa; Thomas A Miller; Yukio Kuramochi; Stefan Frantz; Young Dae Kim; Mark A Marchionni; Ralph A Kelly; Douglas B Sawyer
Journal:  J Mol Cell Cardiol       Date:  2003-12       Impact factor: 5.000

Review 8.  Endothelial cell-cardiomyocyte crosstalk in diabetic cardiomyopathy.

Authors:  Andrea Wan; Brian Rodrigues
Journal:  Cardiovasc Res       Date:  2016-06-10       Impact factor: 10.787

Review 9.  Endothelial cell-cardiomyocyte crosstalk in heart development and disease.

Authors:  Andrea Colliva; Luca Braga; Mauro Giacca; Serena Zacchigna
Journal:  J Physiol       Date:  2019-03-27       Impact factor: 5.182

10.  Neuregulin-1 attenuates experimental cerebral malaria (ECM) pathogenesis by regulating ErbB4/AKT/STAT3 signaling.

Authors:  Mingli Liu; Wesley Solomon; Juan Carlos Cespedes; Nana O Wilson; Byron Ford; Jonathan K Stiles
Journal:  J Neuroinflammation       Date:  2018-04-10       Impact factor: 8.322
View more
  1 in total

1.  CXCL10 is a novel anti-angiogenic factor downstream of p53 in cardiomyocytes.

Authors:  Tri Wahyuni; Shota Tanaka; Ryuta Igarashi; Yoshiaki Miyake; Ayaha Yamamoto; Shota Mori; Yusuke Kametani; Masashi Tomimatsu; Shota Suzuki; Kosei Yokota; Yoshiaki Okada; Makiko Maeda; Masanori Obana; Yasushi Fujio
Journal:  Physiol Rep       Date:  2022-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.